Stock & Company Details
AnaptysBio Inc $ANAB
Price:
N/A
N/A
30M
$1.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-52.68
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ANAB technical indicators
Latest AnaptysBio Inc (ANAB) indicator readings as of 2026-10-09.
ANAB's 14-day RSI is 26.8, in oversold territory. At $45.95 it is trading 18.6% below its 200-day moving average of $56.45, and below its 50-day average of $54.34. Price sits near the lower Bollinger Band ($44.71 to $57.21). ADX reads 37.5, indicating a trending market.
Overview
AnaptysBio Inc is a clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonists. The entity generates revenue from collaborative research and development arrangements.
Finance Bot
Ask your questions
Start by typing a question below.
